Serine protease inhibitors, particularly antithrombin III, are commonly depleted in critically ill patients. The role of serine protease inhibitors in coagulation and anticoagulation is complicated because of their effects at various points in the coagulation pathway ( Fig 1).
Fig. 1 Schematic representation of the contact pathway. Inhibitors, including aprotinin, are shown in the shaded boxes.
Was this article helpful?